All Stories

  1. Effects of intensive lifestyle intervention and gastric bypass on aortic stiffness: A 1‐year nonrandomized clinical study
  2. Validation of a Portable Monitor for the Diagnosis of Obstructive Sleep Apnea in Morbidly Obese Patients
  3. Parental marital status and childhood overweight and obesity in Norway: a nationally representative cross-sectional study
  4. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study
  5. Randomiserte studier – nyttige for hvem?
  6. Effectiveness of a Cognitive Behavioral Therapy for Dysfunctional Eating among Patients Admitted for Bariatric Surgery: A Randomized Controlled Trial
  7. Moral challenges with surgical treatment of type 2 diabetes
  8. Adiposity among children in Norway by urbanity and maternal education: a nationally representative study
  9. The diagnostic accuracy of pocket-size cardiac ultrasound performed by unselected residents with minimal training
  10. Pulmonary function and blood gases after gastric bypass and lifestyle intervention: a comparative study
  11. Obstructive Sleep Apnea after Weight Loss: A Clinical Trial Comparing Gastric Bypass and Intensive Lifestyle Intervention
  12. De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability
  13. Arterial stiffness, lifestyle intervention and a low‐calorie diet in morbidly obese patients—A nonrandomized clinical trial
  14. Impact of instrument error on the estimated prevalence of overweight and obesity in population-based surveys
  15. The effectiveness of secondary and tertiary care lifestyle intervention in morbidly obese patients: a 1-year non-randomized controlled pragmatic clinical trial
  16. Tren deg slank – en myte?
  17. Tidsskriftet bør stille strengere krav til litteratursøk
  18. Predictors of weight loss after an intensive lifestyle intervention program in obese patients: a 1-year prospective cohort study
  19. Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study
  20. Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects
  21. Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin
  22. Dietary changes in obese patients undergoing gastric bypass or lifestyle intervention: a clinical trial
  23. Early Posttransplantation Hyperglycemia in Kidney Transplant Recipients Is Associated With Overall Long-term Graft Losses
  24. A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity
  25. New-Onset Diabetes After Kidney Transplantation—Changes and Challenges
  26. Vitamin status after gastric bypass and lifestyle intervention: a comparative prospective study
  27. Comment on: Chakkera et al. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011;34:2141–2145
  28. Om fedme på dansk
  29. Overvekt hos barn - et bygdeproblem?
  30. Nyresvikt, fedme og kosthold
  31. Om gener og fedme - alt er ikke din skyld!
  32. Viktig bok om overvekt hos barn og unge
  33. Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study
  34. The association of early post-transplant glucose levels with long-term mortality
  35. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
  36. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients
  37. Fedmekirurgi for ungdom?
  38. Tung lærebok om fedme
  39. God bok om endring av helseatferd
  40. Validity of the SF-36 in Patients with Morbid Obesity
  41. Oppfølging etter fedmekirurgi
  42. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study
  43. Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional study
  44. The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction
  45. The Relationship Between Anthropometric Measures, Blood Gases, and Lung Function in Morbidly Obese White Subjects
  46. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
  47. Employment Is Associated with the Health-Related Quality of Life of Morbidly Obese Persons
  48. Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch
  49. Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
  50. Undiagnosed Diabetes in Kidney Transplant Candidates
  51. Comparison of vitamin concentrations after gastric bypass and lifestyle intervention
  52. Morbidly Obese Patients—Who Undergoes Bariatric Surgery?
  53. Sykelig overvekt – ulikt behandlingstilbud
  54. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals
  55. Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction
  56. Fasting Plasma Glucose in the Screening for Type 2 Diabetes in Morbidly Obese Subjects
  57. Glucose tolerance before and after renal transplantation
  58. Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: A cross-sectional study
  59. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
  60. Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation
  61. Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients
  62. Alternativ behandling av fedme
  63. Fedmeepidemien – vi må begynne med barna
  64. Fedmebehandling på svensk – atferdsendring i praksis?
  65. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
  66. Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation
  67. Role of Prednisolone Pharmacokinetics in Postchallenge Glycemia After Renal Transplantation
  68. Peripheral Neuropathy and Severe Malnutrition following Duodenal Switch
  69. Ghrelin, Atherosclerosis, and Glucose: GAG or Causal Relationships?
  70. Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade
  71. Reply
  72. The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
  73. Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
  74. Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation
  75. Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients
  76. Hypoadiponectinemia Is Associated with Insulin Resistance and Glucose Intolerance after Renal Transplantation
  77. Association between insulin resistance and endothelial dysfunction in renal transplant recipients
  78. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
  79. High mortality rates in conservatively managed patients with acute coronary syndrome
  80. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced  -cell damage
  81. Reply
  82. New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection
  83. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
  84. Determinants of insulin secretion after renal transplantation
  85. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation*
  86. Response to Montori et al.
  87. Insulin Resistance After Renal Transplantation
  88. Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study
  89. Risk for posttransplant diabetes mellitus with current immunosuppressive medications
  90. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients.